GeneralConnection.com ➔ Dictionary
Dictionary Search

vasomotor

Synonyms

Adjective

1. constriction

2. dilation, dilatation

Usage
Elinzanetant Reduces Vasomotor Symptoms in Postmenopausal Women: 52-Week Phase 3 Trial Results - Vera Health
Neurokinin receptor antagonists for vasomotor symptoms: from KNDy neurons to clinical translation - Nature
Nonhormonal Therapies for Vasomotor Symptoms of Menopause - Medscape Reference
FDA says "study may proceed" for Vistagen's refisolone nasal spray for vasomotor symptoms - Contemporary OB/GYN
Elinzanetant: Advancing Treatment for Vasomotor Symptoms - Pharmacy Times
Vasomotor Symptoms of Menopause: Facts At-a-Glance for Primary Care - Patient Care Online
Risk factors, management and consequences of severe menopausal vasomotor symptoms - Nature
Pathophysiology of Vasomotor Symptoms in Menopause - Contemporary OB/GYN
How African American Patients Are Affected By Vasomotor Symptoms - Contemporary OB/GYN
Fezolinetant shows significant real-world improvements in vasomotor symptoms, sleep - Contemporary OB/GYN
Key takeaways from real-world data of fezolinetant for vasomotor symptoms - Contemporary OB/GYN
Elinzanetant Pooled Safety Analysis Supports FDA Approval Decision for Vasomotor Symptoms, With James A. Simon, MD - Patient Care Online
Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms - News-Medical
Closing the Gap: Elinzanetant Demonstrates Efficacy for Vasomotor Symptoms in African American Women - Contemporary OB/GYN
Midlife insulin levels influence timing and duration of menopausal vasomotor symptoms - News-Medical
Estetrol Improves Vasomotor Symptoms With No BP Effects - Medscape
Pooled Safety Analysis Supports Elinzanetant for Vasomotor Symptoms Through 52 Weeks - Patient Care Online
Moderate to Severe Vasomotor Symptoms Suggest Perimenopause in Amenorrhea - Clinical Pain Advisor
Noema Pharma to Present Phase 2a Results for Cendifensine - GlobeNewswire
U.S. approval of a new hormone-free treatment option for moderate to severe vasomotor symptoms due to menopause - Bayer
Breast cancer on endocrine therapy: Fezolinetant may rapidly reduce refractory vasomotor symptoms - Vera Health
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms - Pharmacy Times
Managing Vasomotor Symptoms: Understanding the Menopause Transition and Treatment Options - Pharmacy Times
Lynkuet® (elinzanetant) for the Treatment of Vasomotor Symptoms Due to Menopause - MPR - Medical Professionals Reference
Elinzanetant Demonstrates Rapid and Sustained Efficacy in Reducing Vasomotor Symptoms Across OASIS Clinical Trials - Pharmacy Times
EU approval for new hormone-free treatment option for vasomotor symptoms associated with menopause or caused by endocrine therapy for breast cancer - Bayer
Lisa Larkin, MD, on the Importance of Recognizing and Managing Vasomotor Symptoms in Menopause - Patient Care Online
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD - The American Journal of Managed Care® (AJMC®)
Measuring associations between hormonal entropy, the prevalence of vasomotor symptoms, and menstrual dynamics - American Physiological Society Journal
Managing Vasomotor Symptoms With NK3 Receptor Antagonism - Patient Care Online
Vasomotor Symptoms Are Linked to Vascular and Cartilage Structural Changes in Postmenopausal Women - obgyn.onlinelibrary.wiley.com
A New Era in Vasomotor Symptom Treatment - Patient Care Online
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms - Contemporary OB/GYN
Vistagen Receives FDA "Study May Proceed" Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause - Yahoo Finance
Hormone therapy, neurokinin antagonists, and the evolving menopause treatment landscape - Contemporary OB/GYN
New nonhormonal therapies transform hot flash treatment in menopause - Contemporary OB/GYN
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause - The American Journal of Managed Care® (AJMC®)
FDA extends review period for Bayer's elinzanetant for vasomotor symptoms - Contemporary OB/GYN
New menopause drug to target hot flashes without hormones gets FDA approval - ABC7 Chicago
An update on the use of non-hormonal therapies for vasomotor symptoms of menopause - Royal Australian College of General Practitioners (RACGP)
Fezolinetant Can Reduce Menopause Symptoms in Women Who Cannot or Will Not Take Hormone Therapy - American Academy of Family Physicians | AAFP
NHS to offer fezolinetant for menopause‑related hot flushes and night‑sweats - PharmaTimes
FDA Green-Lights Elinzanetant, First Dual NK-1/NK-3 Antagonist, for Moderate to Severe Vasomotor Symptoms of Menopause - Patient Care Online
Elinzanetant recommended for approval in EU as treatment of moderate to severe vasomotor symptoms - Bayer
Fezolinetant (Veozah) for the Treatment of Menopause Symptoms - American Academy of Family Physicians | AAFP
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies - The American Journal of Managed Care® (AJMC®)
Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options - Contemporary OB/GYN
Muna Al-Khaifi: Treating Vasomotor Symptoms in Breast Cancer is Not Just about Comfort - Oncodaily
New Non-Hormonal Menopause Drug Backed by NICE - Medscape
Special Report: Identifying gaps in care - Contemporary OB/GYN
Novel Nonhormonal Drug Approved for Menopause Hot Flashes - MedPage Today
Plant-Based Estrogen Diminished Menopause Symptoms - MedPage Today
Elinzanetant Reduces Frequency, Severity of VMS in Differing Female Populations - Pharmacy Times
Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine - JACC Journals
Menopause drug reduces hot flashes by more than 70%, international clinical trial finds - Medical Xpress
newsGP - Vasomotor symptoms key to perimenopause diagnosis - Royal Australian College of General Practitioners (RACGP)
Hormone Therapy for Menopause: Timing, Safety, and Best Candidates - The American Journal of Managed Care® (AJMC®)
NICE recommends non-hormonal treatment for hot flushes - The Pharmaceutical Journal
Nonhormonal therapies transform menopause care in 2025 - Contemporary OB/GYN
Narcolepsy Patients Show Enhanced Brain Waste Clearance Through Compensatory Vasomotor Activity - Sleep Review
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - Yahoo Finance
How New Pathways Are Easing Vasomotor Symptoms in Breast Cancer Care - Contemporary OB/GYN
Elinzanetant reduces vasomotor symptoms during breast cancer endocrine therapy - medwirenews.com
Fezolinetant shows real-world promise for menopause symptoms - PharmaTimes
Dr Cardoso on the Effect of Elinzanetant on Vasomotor Symptoms in HR+ Breast Cancer - OncLive
How a Mediterranean diet helps women manage menopausal symptoms - News-Medical
Heart Risks of Hormone Therapy for Hot Flashes Double Starting at This Age - MedPage Today
With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds - Fierce Pharma
You Don’t Have To Live With Hot Flashes And Night Sweats - Chatelaine
A new non-hormonal hot flash treatment enters Phase 2 testing in women - Stock Titan
Human NREM Sleep Promotes Brain-Wide Vasomotor and Respiratory Pulsations - Journal of Neuroscience
Elinzanetant reduces vasomotor symptom frequency and intensity in new meta-analysis - Contemporary OB/GYN
AbCellera begins Phase II ABCL635 trial for menopause-related VMS - Clinical Trials Arena
Many physicians still consider VMS to be transient and inconsequential, but new research suggests otherwise—are you all caught up? - MDLinx
New study may offer hope to women with hot flashes, night sweats - UVic News
Elinzanetant for Vasomotor Symptoms From Endocrine Therapy for Breast Cancer - The ASCO Post
You know VMS is underdiagnosed. But are you part of the problem? - MDLinx
2023 Menopause Society Annual Meeting Highlights Vasomotor Symptoms Treatment - Endocrinology Advisor
MHRA approves elinzanetant to treat moderate to severe vasomotor symptoms (hot flushes) caused by menopause - GOV.UK
Phase III OASIS-4 Trial Shows Elinzanetant Significantly Reduces Endocrine Therapy–Related Vasomotor Symptoms in Patients with HR-Positive Breast Cancer - Applied Clinical Trials Online
Two types of vidian neurectomy show efficacy in treating allergic rhinitis and vasomotor rhinitis - Nature
FDA accepts elinzanetant NDA for vasomotor symptoms in menopause - Contemporary OB/GYN
Menopausal Vasomotor Symptoms and Subclinical Atherosclerotic Cardiovascular Disease: A Population‐Based Study - American Heart Association Journals
Menopausal Vasomotor Symptoms: Clinician and Patients Both Need Education, Expert Says - Patient Care Online
Vasomotor symptom frequency linked to diabetes risk - Contemporary OB/GYN
Review: Nonhormone Therapies for Menopausal Hot Flashes - Cleveland Clinic
‘Ignoring hot flushes is wrong’: study challenges assumptions about perimenopause symptoms - The Guardian
Nonhormonal Prescription Therapies for Moderate to Severe Menopause-Related Vasomotor Symptoms - Medical Professionals Reference
Vasomotor symptoms associated with diabetes risk - Contemporary OB/GYN
Elinzanetant Eases Vasomotor Symptoms in HR+ Breast Cancer - Docwire News
Bayer Receives First Global Approval for Lynkuet to Treat Menopause Vasomotor Symptoms - Femtech Insider
Pharmacologic treatment options for vasomotor symptoms - Contemporary OB/GYN
Bayer's challenger to Astellas hot flash drug wins first approval with UK OK - FirstWord Pharma
Elinzanetant significantly reduces frequency of moderate to severe vasomotor symptoms associated with endocrine therapy for breast cancer in Phase III OASIS-4 study - Bayer
Nonpharmacologic Options Can Manage Hot Flashes - Medscape
Elinzanetant found to reduce VMS from endocrine therapy for breast cancer - Contemporary OB/GYN
Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows - Patient Care Online
Navigating Vasomotor Symptoms From Endocrine Therapy in Breast Cancer Treatment - Contemporary OB/GYN
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms - Contemporary OB/GYN
OASIS-4 Trial: Elinzanetant Reduces Frequency of Vasomotor Symptoms Related to Endocrine Therapy for HR-Positive Breast Cancer - Patient Care Online
Foreign Language Equivalents
Foreign Language Equivalents of 'vasomotor'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
vasomotorr,   vasomtoor,   vasmotor,   vasoomtor,   vssomotor,   vaasomotor,   vasomotr,   vasoomotor,   vasomitor,   vasomottor,   vasmootor,   vassomotor,   vsomotor,   vasomoror,   vasootor,   vasomotoor,   vasomootr,   vaso,otor,   vasimotor,   vaomotor,   vasomoor,   vasomotot,   vasonotor,   basomotor,   vaspmotor,   vasomotoe,   vasomoto,   vasomotir,   vasomptor,   casomotor,   asomotor,   vasomotro,   vasomotpr,   vvasomotor,   vasomoter,   vasommotor,   vasomtor,   vsaomotor,   vaaomotor,   vasomootor,   vaosmotor,   vadomotor,   vasomoyor,   avsomotor
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z